Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis
MR McGill, H Jaeschke - Pharmaceutical research, 2013 - Springer
Acetaminophen (APAP) is one of the most widely used drugs. Though safe at therapeutic
doses, overdose causes mitochondrial dysfunction and centrilobular necrosis in the liver …
doses, overdose causes mitochondrial dysfunction and centrilobular necrosis in the liver …
Mechanisms underlying food–drug interactions: inhibition of intestinal metabolism and transport
CS Won, NH Oberlies, MF Paine - Pharmacology & therapeutics, 2012 - Elsevier
Food–drug interaction studies are critical to evaluate appropriate dosing, timing, and
formulation of new drug candidates. These interactions often reflect prandial-associated …
formulation of new drug candidates. These interactions often reflect prandial-associated …
PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses
LL Mazaleuskaya, K Sangkuhl, CF Thorn… - Pharmacogenetics …, 2015 - journals.lww.com
Pharmacokinetics Acetaminophen has a high oral bioavailability (88%); it is well absorbed
and reaches the peak blood concentration within 90min after ingestion [5]. APAP is not …
and reaches the peak blood concentration within 90min after ingestion [5]. APAP is not …
Sensitive detection of acetaminophen with graphene-based electrochemical sensor
Here we report on a high-performance electrochemical sensor for the sensitive detection of
acetaminophen based on graphene, which was simultaneously electrochemically reduced …
acetaminophen based on graphene, which was simultaneously electrochemically reduced …
Application of physiologically based pharmacokinetic modeling to predict acetaminophen metabolism and pharmacokinetics in children
XL Jiang, P Zhao, JS Barrett, LJ Lesko… - CPT …, 2013 - Wiley Online Library
Acetaminophen (APAP) is a widely used analgesic and antipyretic drug that undergoes
extensive phase I and II metabolism. To better understand the kinetics of this process and to …
extensive phase I and II metabolism. To better understand the kinetics of this process and to …
Female gender as a susceptibility factor for drug-induced liver injury
DE Amacher - Human & experimental toxicology, 2014 - journals.sagepub.com
Adverse drug reactions (ADRs) can involve all tissues and organs, but liver injuries are
considered among the most serious. A number of prospective, multicenter studies have …
considered among the most serious. A number of prospective, multicenter studies have …
[HTML][HTML] Hepatoprotective effects of berberine on acetaminophen-induced hepatotoxicity in mice
Z Zhao, Q Wei, W Hua, Y Liu, X Liu, Y Zhu - Biomedicine & …, 2018 - Elsevier
Acetaminophen (APAP) hepatotoxicity remains the leading cause of drug-induced liver
injury due to the lack of safe and effective therapeutic agents. Berberine (BBR) is a natural …
injury due to the lack of safe and effective therapeutic agents. Berberine (BBR) is a natural …
Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk
Identification of genetic polymorphisms that contribute to the risk of developing cancers is
important for cancer prevention. The most recent human genome GRCh38/hg38 assembly …
important for cancer prevention. The most recent human genome GRCh38/hg38 assembly …
Inter-individual differences in response to dietary intervention: integrating omics platforms towards personalised dietary recommendations
Technologic advances now make it possible to collect large amounts of genetic, epigenetic,
metabolomic and gut microbiome data. These data have the potential to transform …
metabolomic and gut microbiome data. These data have the potential to transform …
The use of mode of action information in risk assessment: Quantitative key events/dose-response framework for modeling the dose-response for key events
TW Simon, SS Simons Jr, RJ Preston… - Critical reviews in …, 2014 - Taylor & Francis
The HESI RISK21 project formed the Dose-Response/Mode-of-Action Subteam to develop
strategies for using all available data (in vitro, in vivo, and in silico) to advance the next …
strategies for using all available data (in vitro, in vivo, and in silico) to advance the next …